Sarepta Therapeutics (SRPT)
Develops Duchenne muscular dystrophy medicines and genetic therapies for rare diseases.
$19.43
vs last close−1.39 (−6.66%)
Something off on this page? Send us feedback.
Next report
Nov 4, 26
in 42 days
EPS estimate
$0.17
Revenue estimate
$354.7M
Fiscal quarter
Q3 FY26
EPSReportedEstimate
Feb '25May '25Aug '25Nov '25Feb '26May '26Aug '26Nov '26
Reported$1.50−$4.60$2.02−$1.80−$3.58$3.16−$0.05Pending
Estimate$1.38−$0.87$0.83−$0.73−$1.03$0.98$0.22$0.17
Surprise+8.7%−428.7%+142.8%−147.6%−247.6%+223.8%−123.0%—
RevenueReportedEstimate
Feb '25May '25Aug '25Nov '25Feb '26May '26Aug '26Nov '26
Reported$658.4M$744.9M$611.1M$399.4M$442.9M$730.8M$401.3MPending
Estimate$631.0M$687.5M$530.7M$335.8M$369.6M$474.2M$366.4M$354.7M
Surprise+4.3%+8.3%+15.2%+18.9%+19.8%+54.1%+9.5%—
HistoryUpcoming
| Date / Period | Estimate | Reported | Surprise |
|---|---|---|---|
| Dec 2027 | $0.20 | — | — |
| Sep 2027 | $0.19 | — | — |
| Jun 2027 | $0.21 | — | — |
| Mar 2027 | $0.11 | — | — |
| Dec 2026 | $0.05 | — | — |
| Nov 2026 | $0.17 | — | — |
| Aug 2026 | $0.22 | −$0.05 | −123.0% |
| May 2026 | $0.98 | $3.16 | +223.8% |
| Feb 2026 | −$1.03 | −$3.58 | −247.6% |
| Nov 2025 | −$0.73 | −$1.80 | −147.6% |
| Aug 2025 | |||
| May 2025 | |||
| Feb 2025 | |||
| Nov 2024 | |||
| Aug 2024 | |||
| May 2024 | |||
| Feb 2024 | |||
| Nov 2023 | |||
| Aug 2023 | |||
| May 2023 | |||
| Feb 2023 | |||
| Nov 2022 | |||
| Aug 2022 | |||
| May 2022 | |||
| Mar 2022 | |||
| Nov 2021 | |||
| Aug 2021 | |||
| May 2021 | |||
| Mar 2021 | |||
| Nov 2020 | |||
| Aug 2020 | |||
| May 2020 | |||
| Feb 2020 | |||
| Nov 2019 | |||
| Aug 2019 | |||
| May 2019 | |||
| Feb 2019 | |||
| Oct 2018 | |||
| Aug 2018 | |||
| May 2018 | |||
| Mar 2018 | |||
| Oct 2017 | |||
| Jul 2017 | |||
| Apr 2017 | |||
| Feb 2017 | |||
| Oct 2016 | |||
| Jul 2016 | |||
| May 2016 | |||
| Feb 2016 | |||
| Nov 2015 | |||
| Aug 2015 |
| Date / Period | EPS est | EPS | Surprise | Revenue est | Revenue | Surprise | Reaction |
|---|---|---|---|---|---|---|---|
| Dec 2027 | $0.20 | — | — | $356.8M | — | — | — |
| Sep 2027 | $0.19 | — | — | $355.1M | — | — | — |
| Jun 2027 | $0.21 | — | — | $349.9M | — | — | — |
| Mar 2027 | $0.11 | — | — | $360.9M | — | — | — |
| Dec 2026 | $0.05 | — | — | $353.9M | — | — | — |
| Nov 4, 2026 | $0.17 | — | — | $354.7M | — | — | — |
| Aug 5, 2026 | $0.22 | −$0.05 | −123.0% | $366.4M | $401.3M | +9.5% | +5.3% |
| May 6, 2026 | $0.98 | $3.16 | +223.8% | $474.2M | $730.8M | +54.1% | −9.7% |
| Feb 25, 2026 | −$1.03 | −$3.58 | −247.6% | $369.6M | $442.9M | +19.8% | −8.0% |
| Nov 3, 2025 | −$0.73 | −$1.80 | −147.6% | $335.8M | $399.4M | +18.9% | −33.7% |
| Aug 6, 2025 | |||||||
| May 6, 2025 | |||||||
| Feb 26, 2025 | |||||||
| Nov 6, 2024 | |||||||
| Aug 7, 2024 | |||||||
| May 1, 2024 | |||||||
| Feb 28, 2024 | |||||||
| Nov 1, 2023 | |||||||
| Aug 2, 2023 | |||||||
| May 2, 2023 | |||||||
| Feb 28, 2023 | |||||||
| Nov 2, 2022 | |||||||
| Aug 2, 2022 | |||||||
| May 4, 2022 | |||||||
| Mar 1, 2022 | |||||||
| Nov 3, 2021 | |||||||
| Aug 4, 2021 | |||||||
| May 5, 2021 | |||||||
| Mar 1, 2021 | |||||||
| Nov 5, 2020 | |||||||
| Aug 5, 2020 | |||||||
| May 6, 2020 | |||||||
| Feb 26, 2020 | |||||||
| Nov 7, 2019 | |||||||
| Aug 7, 2019 | |||||||
| May 8, 2019 | |||||||
| Feb 27, 2019 | |||||||
| Oct 24, 2018 | |||||||
| Aug 8, 2018 | |||||||
| May 3, 2018 | |||||||
| Mar 1, 2018 | |||||||
| Oct 25, 2017 | |||||||
| Jul 19, 2017 | |||||||
| Apr 27, 2017 | |||||||
| Feb 28, 2017 | |||||||
| Oct 27, 2016 | |||||||
| Jul 19, 2016 | |||||||
| May 5, 2016 | |||||||
| Feb 25, 2016 | |||||||
| Nov 5, 2015 | |||||||
| Aug 6, 2015 |